Variant · Snv
POMGNT1 NM_017739.4(POMGNT1):c.652+1G>A
CI-VAR-00005392Explore in graph →NM_017739.4:c.652+1G>AClinVar 3999 rs386834035
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3999 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3; Muscle eye brain disease; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3; Muscular dystrophy-dystroglycanopathy; Ovarian serous cystadenocarcinoma | germline | 6 | Jun 17, 2023 | clinvar |